At a glance
ClinicalIndex Comparison RecordN/AUnknown· 95 enrolled
Drug / intervention
rabeprazole +3 moredrug
Likely dose
rabeprazole 10mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Value of Narrow-band Imaging, Autofluorescence Imaging & White-light Imaging on Gastroesophageal Reflux Disease
In Brief
An observational study evaluating symptom questionaire, pH monitoring, and 2 other interventions for Gastroesophageal Reflux Disease. Targeting 95 participants across 1 site.
Detailed Summary
Aim of this study is to compare the efficacy of narrow band imaging (NBI) and autofluorescence imaging (AFI) to distinguish subtle mucosal change related to acid reflux that is not visible in standard white light imaging (WLI) endoscopy, and help indicating the diagnosis of gastroesophageal reflux disease (GERD).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastroesophageal Reflux Disease
CountriesChina
Collaborators--
Timeline
N/AUnknownOverdue
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2011
First PostedJan 2012
Primary CompletionJun 2012
Study CompletionDec 2016
TodayJul 2026
First PostedJan 6, 2012
Enrollment StartJan 1, 2011
Primary CompletionJun 1, 2012
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 14.5 years ago
Interventions
symptom questionaireother
GerdQ questionaire
pH monitoringprocedure
24-hour pH monitoring
Tri-modal imaging endoscopyprocedure
To investigate WLI,NBI and AFI
rabeprazoledrug
10mg, bid, p.o.